Literature on the association between cannabis use and body mass index (BMI) among adults suggests that greater cannabis use is associated with a lower BMI. However, results are mixed among adolescents, with both cross-sectional and longitudinal studies finding positive, negative, and nonsignificant associations between cannabis use and BMI. This longitudinal study aims to shed light on these associations by prospectively examining the associations between cannabis use and BMI across a 2-year window in a large sample of adolescent cannabis users. Participants were 401 adolescents ages 14-17 at baseline who were at risk for escalation in their use of cannabis. We conducted a parallel process latent growth curve model to examine associations between the cannabis use intercept, BMI intercept, cannabis use slope, and BMI slope. Results showed that baseline BMI predicted a positive and significant association with cannabis use slope. In addition, there was a significant and negative correlation between the cannabis use slope and the BMI slope. These significant associations remained after controlling for relevant covariates. Results are consistent with the adult literature that reports a negative association between cannabis use and BMI. Future research should focus on uncovering the mechanisms that may drive the association between cannabis use and BMI.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173669 | PMC |
| http://dx.doi.org/10.1089/can.2019.0091 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Planned versus unplanned alcohol and cannabis use: Motivational and contextual correlates among sexual minority women and gender diverse individuals.
Alcohol Clin Exp Res (Hoboken)
January 2025
Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, Washington, USA.
Background: Unplanned alcohol use has been theorized to contribute to experiencing more consequences at the daily level, and several risk factors have been identified in the general population. However, it remaines unclear whether these risk factors apply to sexual and gender minorities (SGM); if unique risk factors for substance use among SGM (e.g.
View Article and Find Full Text PDFPsychedelic-assisted treatment for substance use disorder: A narrative systematic review.
Addiction
January 2025
Addictions Department, School of Academic Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Background And Aims: This is the first systematic review of the extant literature on all major psychedelic-assisted treatment for alcohol use disorder (AUD), tobacco use disorder (TUD) and other substance use disorders (SUD). We aimed to summarise the evidence for efficacy of psychedelic-assisted treatment for AUD, TUD, and SUD; to evaluate its quality; and to offer recommendations for research.
Methods: This was a prospectively registered narrative systematic review of open-label, randomised controlled trials (RCT), and observational studies of d-lysergic acid diethylamide (LSD), mescaline, psilocybin, ayahuasca, ketamine, ibogaine and 3,4-methylenedioxymethamphetamine (MDMA).
Methamphetamine-Associated Psychosis and Criminal Responsibility.
J Am Acad Psychiatry Law
January 2025
Dr. Engelson is a fellow in forensic psychiatry, Dr. Sloan is an Assistant Professor, and Dr. Gulrajani is an Associate Professor, Department of Psychiatry and Behavioral Sciences, University of Minnesota - Twin Cities, Minneapolis, MN. Dr. Teravskis is a resident physician, Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Birmingham, AL.
Stimulants are among the most widely used substances in the world after cannabis, with a rapid rise in methamphetamine use in the last 15 years. Methamphetamine has a high propensity to cause psychosis ranging from transient psychosis during acute intoxication to persisting psychosis with similarities to schizophrenia. Although the former condition may not abrogate criminal responsibility, the latter is recognized as a basis for an exculpatory mental state in a majority of jurisdictions across the United States.
View Article and Find Full Text PDFEffects of compassion satisfaction, burnout, and secondary traumatic stress on current drug use among healthcare workers: Differences by occupational level.
Addict Behav Rep
June 2025
Department of Health and Kinesiology, University of Illinois Urbana-Champaign.
Work-related stress has been well-examined among physicians, but little is known about how it might affect drug use or healthcare workers in lower-wage occupations characterized by high job demands and low occupational autonomy (e.g., medical assistants, nursing assistants).
View Article and Find Full Text PDFCannabis consumption and risk of asthma: a systematic review and meta-analysis.
BMC Pulm Med
January 2025
Global Health and Infectious Diseases Control Institute, Nasarawa State University, Keffi, Nigeria.
Background: Cannabis is the third most widely used psychoactive substance globally, and its consumption has been increasing, particularly with the growing trend of legalization for medicinal and recreational use. Recent studies have raised concerns about the potential impact of cannabis on respiratory health, specifically the risk of asthma, a significant public health concern. This systematic review aimed to consolidate research on the association between cannabis use and the risk of asthma.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!